Ask AI
HER2CLIMB-05
HER2CLIMB-05: Tucatinib vs Placebo Added to Trastuzumab + Pertuzumab as First-line Maintenance Therapy for HER2+ MBC

Released: December 19, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 19, 2025